The largest provider of medical marijuana in Israel just isn’t distributing or promoting merchandise from its facility in Biriya after the Ministry of Health raised questions over a brand new drying course of – however the firm expects the power to be up and operating in a matter of days.
Tikun Olam CEO Aharon Lutzky stated the corporate has been cooperating with the ministry and is awaiting check outcomes from an unbiased laboratory.
“Until these results are approved, no products that were subject to the inspection will be distributed or sold,” he stated in a press release to Marijuana Business Daily.
A supply within the Ministry of Health confirmed the determination was made by the medical cannabis unit. The supply, who is just not approved to talk with the media and thus requested anonymity, stated the issue is “expected to be solved within a few days.”
Tikun Olam is taken into account a pacesetter within the remedy of sufferers with medical cannabis.
The firm has about 15,000 of Israel’s 38,000 cannabis sufferers.
Stephen Gardner, Tikun Olam’s chief advertising officer, stated the corporate expects to have the lab outcomes Sunday.
“The ministry came in, looked at the drying technique that we were doing and said we need to have it tested before it can be processed,” he stated.
CEO Lutzky stated the manufacturing facility in Biriya just lately adopted new strategies of drying cannabis to hurry manufacturing time resulting from hovering demand for the corporate’s merchandise.
“Tikun Olam stands by that there was and will be no situation in which we will provide to our patients anything other than a high-quality product that meets the strict standards set by the Ministry of Health,” he stated.
The Calcalist, a every day enterprise newspaper, reported that the “temporary closure” can be in impact till the difficulty is resolved.
The Calcalist reported final week that Tikun Olam acquired the primary license in Greece to develop and export medical cannabis to Europe.
Tikun Olam’s worldwide community additionally consists of an unique alliance with Canada’s MedReleaf, a licensed producer of medical marijuana now owned by Alberta-based Aurora Cannabis.
Matt Lamers could be reached at [email protected]
To join our weekly worldwide marijuana enterprise publication, click on right here.